MRK vs RAL · P/E 33, rev $65.01B vs rev $2.07B
Merck & Company Inc (MRK) versus Ralliant Corporation Common Stock (RAL) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Ralliant Corporation Common Stock (RAL) is a electronic components company listed on NYSE.
Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported RAL revenue for 2025-12-31 was $2.07B. Net income was -$1.22B. Revenue was down 4.0% from 2024-12-31 to 2025-12-31. RAL currently screens at market cap $7.76B.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. RAL currently screens at market cap $7.76B.
Not investment advice. Open the MRK and RAL stock pages for the full models.
Not investment advice.